Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Renyan Gong"'
Autor:
Lei Huo, Wenxin Wei, Zhenlin Yan, Zhengqing Lei, Yanting Xie, Renyan Gong, Shengyu Huang, Ningyang Jia, Yong Xia
Publikováno v:
Cell & Bioscience, Vol 9, Iss 1, Pp 1-12 (2019)
Abstract Background Portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) is a sign of advanced stage disease, which is associated with poor prognosis. Liver resection (LR) may provide better prognosis in selected patients. In the pre
Externí odkaz:
https://doaj.org/article/a843758ad7344b1497c1e24c1805b0b2
Publikováno v:
Lasers in Surgery and Medicine. 53:684-694
BACKGROUND AND OBJECTIVES Vasospasm is a thorny problem often encountered in microvascular surgery that seriously threatens the survival of vascularized tissue transfers. This investigation is dedicated to establishing a model of vasospasm and to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e50a4501fc1ee0d6b288d3de89353e83
https://doi.org/10.1002/lsm.23347
https://doi.org/10.1002/lsm.23347
Publikováno v:
Ann Transl Med
Background The tumor immune microenvironment is pivotal in predicting clinical outcomes and therapeutic efficacy in cancer patients. This study aims to develop an immune prediction model (IPM) to effectively predict prognosis and immunotherapeutic re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd9365cc09fb27d2f9d4714fcebc58a8
https://pubmed.ncbi.nlm.nih.gov/33241026
https://pubmed.ncbi.nlm.nih.gov/33241026
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 35(10)
Background: Hepatocellular carcinoma (HCC), the fourth leading cause of cancer-related deaths worldwide, has increased public concern. Data from previous work have validated that long noncoding RNA...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b611c596e0f973876af29555e42e470
https://pubmed.ncbi.nlm.nih.gov/32397799
https://pubmed.ncbi.nlm.nih.gov/32397799
Autor:
Huo, Lei, Wenxin Wei, Zhenlin Yan, Zhengqing Lei, Yanting Xie, Renyan Gong, Shengyu Huang, Ningyang Jia, Xia, Yong
Additional file 2. Supplementary method.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::557e1497e21c4a3770950445bf599aaf
Autor:
Wan Yee Lau, Jun Li, Yizhou Wang, Dong Wu, Xuying Wan, Meng-Chao Wu, Guanghua Liu, Lehua Shi, Kui Wang, Zhenlin Yan, Yong Xia, Renyan Gong, Feng Shen
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(9)
Purpose This study aimed to establish an effective prognostic nomogram for intrahepatic cholangiocarcinoma (ICC) after partial hepatectomy. Patients and Methods The nomogram was based on a retrospectively study on 367 patients who underwent partial h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6635088f773b171a7c6760dae8901e
https://pubmed.ncbi.nlm.nih.gov/23358969
https://pubmed.ncbi.nlm.nih.gov/23358969
Publikováno v:
Biochemical and biophysical research communications. 418(3)
Hepatocellular carcinoma (HCC) is one of leading causes of cancer-related death with a heterogeneous patient demographic and divergent pathogenic pathways. Sorafenib is the first effective drug approved for the treatment of HCC. Although it is known
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1faf79473aac0d2dd3c3298c88239f8
https://pubmed.ncbi.nlm.nih.gov/22285185
https://pubmed.ncbi.nlm.nih.gov/22285185
Publikováno v:
Biochemical and Biophysical Research Communications. 420:939
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8f1c272df6292273bf0b2d32bfcb952
https://doi.org/10.1016/j.bbrc.2012.03.042
https://doi.org/10.1016/j.bbrc.2012.03.042
Autor:
Yizhou Wang, Jun Li, Yong Xia, Renyan Gong, Kui Wang, Zhenlin Yan, Xuying Wan, Guanghua Liu, Dong Wu, Lehua Shi, Wanyee Lau, Mengchao Wu, Feng Shen
Publikováno v:
Journal of Clinical Oncology; 3/20/2013, Vol. 31 Issue 9, p1188-1195, 8p
Autor:
Jun L; Department of Hepatic Surgery, Second Military Medical University, Shanghai, People's Republic of China., Zhenlin Y, Renyan G, Yizhou W, Xuying W, Feng X, Yong X, Kui W, Jian L, Dong W, Hongyang W, Lehua S, Mengchao W, Feng S
Publikováno v:
The oncologist [Oncologist] 2012; Vol. 17 (7), pp. 963-9. Date of Electronic Publication: 2012 May 31.